Exam 11: The Opioids
Exam 1: Principles of Pharmacology63 Questions
Exam 2: Structure and Function of the Nervous System57 Questions
Exam 3: Chemical Signaling by Neurotransmitters and Hormones54 Questions
Exam 4: Methods of Research in Psychopharmacology67 Questions
Exam 5: Catecholamines60 Questions
Exam 6: Serotonin60 Questions
Exam 7: Acetylcholine56 Questions
Exam 8: Glutamate and Gaba61 Questions
Exam 9: Drug Abuse and Addiction57 Questions
Exam 10: Alcohol58 Questions
Exam 11: The Opioids71 Questions
Exam 12: Psychomotor Stimulants: Cocaine, Amphetamine, and Related Drugs72 Questions
Exam 13: Nicotine and Caffeine63 Questions
Exam 14: Marijuana and the Cannabinoids59 Questions
Exam 15: Hallucinogens, Pcp, and Ketamine58 Questions
Exam 16: Inhalants, Ghb, and Anabolic-Androgenic Steroids57 Questions
Exam 17: Disorders of Anxiety and Impulsivity and the Drugs Used to Treat These Disorders60 Questions
Exam 18: Affective Disorders: Antidepressants and Mood Stabilizers60 Questions
Exam 19: Schizophrenia: Antipsychotic Drugs54 Questions
Exam 20: Neurodegenerative Diseases, by Jennifer R : Yates, Lander University57 Questions
Select questions type
Describe the basic components of Himmelsbach's model of tolerance and withdrawal and provide physiological evidence that supports his ideas.
(Essay)
4.8/5
(66)
Cite evidence showing that dopamine plays a key role in the reinforcing value of opiates. Identify two dopamine brain areas that are particularly important in this role. Researchers have recently proposed that dopamine is not required for this rewarding effect. Explain this statement.
(Essay)
4.9/5
(72)
What is the rationale for the development of dual µ-receptor/NOP-R agonists? What research findings suggest these agents have clinical potential as analgesics?
(Essay)
4.8/5
(78)
Describe the more recent buprenorphine treatments for opioid withdrawal. What are the advantages of these newer types of treatments?
(Essay)
4.7/5
(65)
How do the different constitutive states of the µ-receptor affect different pain signaling pathways, specifically the beta arrestin protein signaling pathway and G-protein mediated signaling? What were the results of studies on these pain signaling pathways in mice and humans?
(Essay)
4.8/5
(72)
How has MEG technology helped to distinguish between fast and slow pain systems?
(Essay)
4.9/5
(81)
Which preparation was initially used to study the effects of pharmacological agents on the opiate receptor?
(Multiple Choice)
4.9/5
(84)
Since 1999, overdose deaths involving opioids have increased by more than _______, with the majority of this increase due to deaths related to _______ use.
(Multiple Choice)
4.8/5
(83)
Which statement about pain perception and opiate action at supraspinal levels is false?
(Multiple Choice)
4.9/5
(74)
Which of the following is not an advantage of buprenorphine maintenance compared to methadone maintenance?
(Multiple Choice)
4.7/5
(63)
A model of the neurobiology of opiate reinforcement suggests that opiates produce their effects by inhibiting _______ neurons.
(Multiple Choice)
4.7/5
(65)
Distinguish between naturally occurring opiates, synthetic opiates, semisynthetic opiates, and endogenous opioids. Provide examples of each.
(Essay)
4.9/5
(78)
Both "early" and "late" pain are associated with neural activity in the
(Multiple Choice)
4.8/5
(94)
Some researchers believe that opiates exert their effects on reinforcement by affecting cell bodies in the _______ that release _______.
(Multiple Choice)
4.7/5
(71)
Showing 21 - 40 of 71
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)